B. Riley Wealth Advisors, Inc. - ACELRX PHARMACEUTICALS INC ownership

ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 85 filers reported holding ACELRX PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.25 and the average weighting 0.4%.

Quarter-by-quarter ownership
B. Riley Wealth Advisors, Inc. ownership history of ACELRX PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$22,000
-99.9%
3,2000.0%0.00%
-100.0%
Q2 2014$32,800,000
+51150.0%
3,200
-43.9%
0.01%
-60.0%
Q4 2013$64,000
-42.9%
5,700
-52.9%
0.02%
-47.4%
Q2 2013$112,00012,1090.04%
Other shareholders
ACELRX PHARMACEUTICALS INC shareholders Q4 2013
NameSharesValueWeighting ↓
Perceptive Advisors 5,408,728$17,037,0000.97%
WealthTrust Axiom LLC 140,000$441,0000.16%
Palo Alto Investors LP 1,032,715$3,253,0000.15%
SHEPHERD KAPLAN KROCHUK, LLC 49,761$157,0000.08%
Joel Isaacson & Co., LLC 80,660$254,0000.05%
Malaga Cove Capital, LLC 10,250$31,0000.02%
Cornerstone Capital, Inc. 30,000$95,0000.02%
Granahan Investment Management 31,298$99,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 244,150$769,0000.01%
Advisor Group, Inc. 117,657$371,0000.01%
View complete list of ACELRX PHARMACEUTICALS INC shareholders